TherapeuticsMD, Inc.
TXMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000025743
No open-market purchases or sales by TherapeuticsMD, Inc. insiders were filed in the last 90 days; 44 institutions reported holding it in 13F filings for Q2 2026, worth $8.10M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in TherapeuticsMD, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- 0 vs. Q2 2024
- Shares held
- 3.38M
- +95.5K (+2.9%) vs. Q2 2024
- Total value
- $5.61M
- +$322.8K (+6.1%) vs. Q2 2024
- New holders
- 5
- 3 more added
- Sold out
- 5
- 5 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TXMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 44 | $8.10M |
| Q1 2026 | 49 | $7.94M |
| Q4 2025 | 44 | $5.52M |
| Q3 2025 | 46 | $3.54M |
| Q2 2025 | 42 | $3.78M |
| Q1 2025 | 42 | $3.09M |
| Q4 2024 | 41 | $3.03M |
| Q3 2024 | 37 | $5.61M |
| Q2 2024 | 38 | $5.49M |
| Q1 2024 | 43 | $7.73M |
| Q4 2023 | 39 | $7.32M |
| Q3 2023 | 36 | $9.02M |
| Q2 2023 | 42 | $12.5M |
| Q1 2023 | 41 | $11.7M |
| Q4 2022 | 44 | $19.4M |
| Q3 2022 | 43 | $13.8M |
| Q2 2022 | 53 | $20.3M |
| Q1 2022 | 125 | $40.4M |
| Q4 2021 | 132 | $44.1M |
| Q3 2021 | 150 | $98.2M |
| Q2 2021 | 155 | $203.9M |
| Q1 2021 | 162 | $237.0M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding TherapeuticsMD, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 154 | $0 | 0.00% | −80−34.2% | Reduced |
| TSFG, LLC | 64 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2 | $0 | 0.00% | +2 | New |
| EverSource Wealth Advisors, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Sterling Capital Management LLC | 1 | $2 | 0.00% | +1 | New |
| Guardian Wealth Management, Inc. | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Assetmark, Inc | 4 | $7 | 0.00% | +4 | New |
| Harbour Investments, Inc. | 8 | $13 | 0.00% | 00.0% | Unchanged |
| Provenance Wealth Advisors, LLC | 20 | $33 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 40 | $66 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 56 | $92 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 80 | $133 | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 120 | $199 | 0.00% | 00.0% | Unchanged |
| Principal Securities, Inc. | 126 | $209 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 144 | $239 | 0.00% | −27−15.8% | Reduced |
| US Bancorp | 246 | $408 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 293 | $486 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 494 | $820 | 0.00% | +7+1.4% | Added |
| Capital Performance Advisors LLP | 600 | $996 | 0.00% | +600 | New |
| National Bank of Canada | 610 | $1.01K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,270 | $3.77K | 0.00% | −1,264−35.8% | Reduced |
| UBS Group AG | 4,847 | $8.05K | 0.00% | −4,269−46.8% | Reduced |
| FMR LLC | 8,289 | $13.8K | 0.00% | 00.0% | Unchanged |
| J. Goldman & Co LP | 13,562 | $22.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 16,457 | $27.3K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 22,470 | $37.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 30,100 | $50.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 34,000 | $56.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 108,333 | $179.9K | 0.00% | +12,856+13.5% | Added |
| BlackRock, Inc. | 116,132 | $192.8K | 0.00% | +116,132 | New |
| Morgan Stanley | 131,719 | $218.7K | 0.00% | +118+0.1% | Added |
| ADAR1 Capital Management, LLC | 270,160 | $448.5K | 0.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 387,582 | $643.4K | 0.00% | 00.0% | Unchanged |
| Tejara Capital Ltd | 401,446 | $666.4K | 0.32% | −491−0.1% | Reduced |
| Clearline Capital LP | 636,622 | $1.06M | 0.09% | 00.0% | Unchanged |
| Rubric Capital Management LP | 1,192,191 | $1.98M | 0.03% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,359−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,576−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −122−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |